Today’s guest post comes from Russel Allinson, Chief Executive Officer at Therigy.
Russel describes the current shift from volume-based to value-based contracting for enhanced population health and patient care. He explains Geisinger’s innovative and successful Medication Therapy Disease Management Program.
Russel highlights how TherigySTM enables the transition from volume-based to value-based contracting. The system’s new features help specialty pharmacies better manage care delivery, tracking, and reporting to stakeholders, while maintaining focus on the bottom line.
Read on for Russ’s insights.
Read more »
Source: Post feed
